Today we are discussing one more pharma stock from small cap segments,
" BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD."
BIBCL is a leading biotechnology company based in Uttar Pradesh India. The company is a Govt. of India Undertaking and has its OPV plant in state of Uttar Pradesh, India. The company currently manufactures and produces a range of pharmaceuticals products such as Oral Polio Vaccines (OPV Vaccine), Zinc Tablet & Diarrhea Management Kit etc.
Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science & Technology, Government of India. BIBCOL was established as a Public Sector Unit in 1989, with the aim to achieve self sufficiency for the nation with respect to production and supply of high quality polio vaccine, a dream project of the Former Prime Minister Late Shri. Rajiv Gandhi.
BIBCL'S principal mission is to save the lives of millions of children from avoidable disability, through polio vaccination. Since its inception, it has contributed significantly to the eradication of Poliomyelitis in the country through the National Immunization Program. BIBCL is the pioneer in the field of polio vaccines, capturing 60% of total market share in India. . Based on the performance of the company and its world class WHO-cGMP certified infrastructure, highly skilled manpower and constant support from DBT, Government of India,
|Oral Polio Vaccine|
|Zinc Dispersable Tablet|